⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18342668 | 0.76 | KDM4D (0.41) | — | |
| SCHEMBL4720267 | 0.75 | — | — | |
| SCHEMBL2446855 | 0.67 | VDR (0.37) | — | |
| SCHEMBL13703365 | 0.67 | CYP1A2 (0.32) | — | |
| SCHEMBL1837583 | 0.66 | — | — | |
| SCHEMBL4790981 | 0.65 | — | — | |
| SCHEMBL3700878 | 0.63 | — | — | |
| SCHEMBL8385183 | 0.62 | — | — | |
| SCHEMBL16785658 | 0.62 | — | — | |
| SCHEMBL92520 | 0.62 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 35 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118924907-B | Multifunctional DNA nanosphere and preparation method and application thereof | 南通大学附属医院 | 2025-05-27 | — | — | CN | disclosed |
| CN-118924907-A | Multifunctional DNA nanosphere and preparation method and application thereof | 南通大学附属医院 | 2024-11-12 | — | — | CN | disclosed |
| US-12019078-B2 | Macromolecule analysis employing nucleic acid encoding | Encodia, Inc. (US) | 2024-06-25 | — | — | US | disclosed |
| US-20240125792-A1 | KITS FOR ANALYSIS USING NUCLEIC ACID ENCODING AND/OR LABEL | DF PEPTIDE ACQUISITION LLC | 2024-04-18 | — | — | US | disclosed |
| US-11959922-B2 | Macromolecule analysis employing nucleic acid encoding | Encodia, Inc. (US) | 2024-04-16 | — | — | US | disclosed |
| EP-4299803-A2 | MACROMOLECULE ANALYSIS EMPLOYING NUCLEIC ACID ENCODING | Encodia, Inc. (US) | 2024-01-03 | — | — | EP | disclosed |
| US-20230346986-A1 | METHODS AND AGENTS FOR THE DETECTION AND TREATMENT OF CANCER | NORTHWESTERN UNIVERSITY | 2023-11-02 | — | — | US | disclosed |
| US-20230340458-A1 | METHODS AND KITS USING NUCLEIC ACID ENCODING AND/OR LABEL | Encodia, Inc. (US) | 2023-10-26 | — | — | US | disclosed |
| US-11782062-B2 | Kits for analysis using nucleic acid encoding and/or label | Encodia, Inc. (US) | 2023-10-10 | — | — | US | disclosed |
| EP-3452591-B1 | MACROMOLECULE ANALYSIS EMPLOYING NUCLEIC ACID ENCODING | ENCODIA INC (US) | 2023-08-16 | — | — | EP | disclosed |
| US-20190321492-A1 | Gd(III)-Dithiolane Gold Nanoparticle Conjugates | NORTHWESTERN UNIVERSITY | 2019-10-24 | — | — | US | disclosed |
| US-10406249-B2 | Gd(III)-dithiolane gold nanoparticle conjugates | NORTHWESTERN UNIVERSITY (US) | 2019-09-10 | — | — | US | disclosed |
| US-20190145982-A1 | MACROMOLECULE ANALYSIS EMPLOYING NUCLEIC ACID ENCODING | Encodia, Inc. (US) | 2019-05-16 | — | — | US | disclosed |
| EP-3452591-A1 | MACROMOLECULE ANALYSIS EMPLOYING NUCLEIC ACID ENCODING | Encodia, Inc. (US) | 2019-03-13 | — | — | EP | disclosed |
| WO-2017192633-A9 | MACROMOLECULE ANALYSIS EMPLOYING NUCLEIC ACID ENCODING | PROCURE LIFE SCIENCES INC. (US) | 2017-12-14 | — | — | WO | disclosed |
| WO-2017192633-A1 | MACROMOLECULE ANALYSIS EMPLOYING NUCLEIC ACID ENCODING | PROCURE LIFE SCIENCES INC. (US) | 2017-11-09 | — | — | WO | disclosed |
| US-20170074859-A1 | Graphene Oxide Cellular Delivery of Hydrophilic Small Molecules | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2017-03-16 | — | — | US | disclosed |
| US-20160375154-A1 | Gd(III)-Dithiolane Gold Nanoparticle Conjugates | NORTHWESTERN UNIVERSITY | 2016-12-29 | — | — | US | disclosed |
| US-20100234450-A1 | Molecular targeting agents | UNIVERSITY OF IOWA RESEARCH FOUNDATION | 2010-09-16 | — | — | US | disclosed |
| WO-2008120016-A1 | MODIFIED NUCLEIC ACIDS | UNIVERSITY OF SOUTHAMPTON (GB) | 2008-10-09 | — | — | WO | disclosed |